58 related articles for article (PubMed ID: 8690901)
21. The extract of syngeneic keratinocytes enhances IgE production from BALB/c mouse splenic lymphocytes in vitro.
Morimoto K; Nabeshima Y; Mochizuki M; Oomizu S; Yamamoto S; Hide M
Arch Dermatol Res; 2006 Feb; 297(8):358-66. PubMed ID: 16402182
[TBL] [Abstract][Full Text] [Related]
22. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
23. TRANCE together with IL-7 induces pre-B cells to proliferate.
Kato I; Sato H; Kudo A
Eur J Immunol; 2003 Feb; 33(2):334-41. PubMed ID: 12548564
[TBL] [Abstract][Full Text] [Related]
24. TLR7/8 ligand, R-848, inhibits IgE synthesis by acting directly on B lymphocytes.
Shen E; Lu L; Wu C
Scand J Immunol; 2008 Jun; 67(6):560-8. PubMed ID: 18397197
[TBL] [Abstract][Full Text] [Related]
25. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10.
O'Garra A; Chang R; Go N; Hastings R; Haughton G; Howard M
Eur J Immunol; 1992 Mar; 22(3):711-7. PubMed ID: 1547817
[TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
[TBL] [Abstract][Full Text] [Related]
27. IL-27 induces the production of IgG1 by human B cells.
Boumendjel A; Tawk L; Malefijt Rde W; Boulay V; Yssel H; Pène J
Eur Cytokine Netw; 2006 Dec; 17(4):281-9. PubMed ID: 17353163
[TBL] [Abstract][Full Text] [Related]
28. Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice.
Lattanzio G; Libert C; Aquilina M; Cappelletti M; Ciliberto G; Musiani P; Poli V
Am J Pathol; 1997 Sep; 151(3):689-96. PubMed ID: 9284817
[TBL] [Abstract][Full Text] [Related]
29. Suppression of IgE responses in CD23-transgenic animals is due to expression of CD23 on nonlymphoid cells.
Payet-Jamroz M; Helm SL; Wu J; Kilmon M; Fakher M; Basalp A; Tew JG; Szakal AK; Noben-Trauth N; Conrad DH
J Immunol; 2001 Apr; 166(8):4863-9. PubMed ID: 11290762
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of B-lymphocyte clonal proliferation by spleen cells from plasmacytoma-bearing mice.
Hamburger AW
J Natl Cancer Inst; 1980 Dec; 65(6):1337-43. PubMed ID: 6968847
[TBL] [Abstract][Full Text] [Related]
31. Estrogen promotes B cell activation in vitro through down-regulating CD80 molecule expression.
Fu Y; Li L; Liu X; Ma C; Zhang J; Jiao Y; You L; Chen ZJ; Zhao Y
Gynecol Endocrinol; 2011 Aug; 27(8):593-6. PubMed ID: 21726119
[TBL] [Abstract][Full Text] [Related]
32. The expression of murine B cell CD23, in vivo, is regulated by its ligand, IgE.
Kisselgof AB; Oettgen HC
Int Immunol; 1998 Sep; 10(9):1377-84. PubMed ID: 9786437
[TBL] [Abstract][Full Text] [Related]
33. Circularly permuted interleukin 4 retains proliferative and binding activity.
Kreitman RJ; Puri RK; McPhie P; Pastan I
Cytokine; 1995 May; 7(4):311-8. PubMed ID: 8589260
[TBL] [Abstract][Full Text] [Related]
34. CCL19 and CXCL13 synergistically regulate interaction between B cell acute lymphocytic leukemia CD23+CD5+ B Cells and CD8+ T cells.
Wang X; Yuling H; Yanping J; Xinti T; Yaofang Y; Feng Y; Ruijin X; Li W; Lang C; Jingyi L; Zhiqing T; Jingping O; Bing X; Li Q; Chang AE; Sun Z; Youxin J; Jinquan T
J Immunol; 2007 Sep; 179(5):2880-8. PubMed ID: 17709502
[TBL] [Abstract][Full Text] [Related]
35. TLR4-mediated signaling induces MMP9-dependent cleavage of B cell surface CD23.
Jackson L; Cady CT; Cambier JC
J Immunol; 2009 Aug; 183(4):2585-92. PubMed ID: 19635918
[TBL] [Abstract][Full Text] [Related]
36. Prostaglandins, but not tumor-derived IL-10, shut down concomitant tumor-specific CTL responses during murine plasmacytoma progression.
Specht C; Bexten S; Kölsch E; Pauels HG
Int J Cancer; 2001 Mar; 91(5):705-12. PubMed ID: 11267984
[TBL] [Abstract][Full Text] [Related]
37. CD23 defines two distinct subsets of immature B cells which differ in their responses to T cell help signals.
Chung JB; Sater RA; Fields ML; Erikson J; Monroe JG
Int Immunol; 2002 Feb; 14(2):157-66. PubMed ID: 11809735
[TBL] [Abstract][Full Text] [Related]
38. c-Rel plays a key role in deficient activation of B cells from a non-X-linked hyper-IgM patient.
Lu KT; Sinquett FL; Dryer RL; Song C; Covey LR
Blood; 2006 Dec; 108(12):3769-76. PubMed ID: 16896156
[TBL] [Abstract][Full Text] [Related]
39. Interleukin 6 is essential for in vivo development of B lineage neoplasms.
Hilbert DM; Kopf M; Mock BA; Köhler G; Rudikoff S
J Exp Med; 1995 Jul; 182(1):243-8. PubMed ID: 7790819
[TBL] [Abstract][Full Text] [Related]
40. Visualization of immunoglobulins on the cell surface of mouse plasma cell tumor (X5563) by immunoenzymatic method.
Takahashi KP
Osaka City Med J; 1980; 26(2):117-23. PubMed ID: 7027125
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
